ABSTRACT
Recurrent stenosis is a problem after any type of esophageal dilatation. Steroids, Botulinum toxin and mitomycin have all been injected into esophageal strictures to reduce this tendency, with limited success. Indwelling stents can be used to maintain the esophageal lumen. However, problems with stent migration, erosion and trauma associated with removal limit their widespread use in children. Biodegradable stents are being developed which may have a major impact on the management of esophageal strictures in the future. However, for practical purposes, the majority of strictures in children have to be managed by repeated dilatation unless esophageal replacement is considered.
